Recently, the Trump administration outlined a series of proposals intended to significantly reduce costs for Medicare patients and reform hospital payment structures. The administration claims that new rules could save Medicare patients approximately $1.1 billion on prescription drugs. Among the proposed changes is a reduction in 340B drug reimbursements, which is part of a broader strategy to modify hospital payments for outpatient services and imaging. Additionally, the plans include increasing payment rates for outpatient departments while aiming to cut profits on drug markups from hospitals. These moves have resulted in a rise in healthcare stocks, indicating market optimism surrounding the changes.